TrialBMJ open2017

Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.

Jamie B Oughton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.